Regardless of Preliminary skepticism, current advancements in peptide drug discovery have rejuvenated interest in peptides as therapeutic agents, with about 70 peptides presently marketed and several other Other individuals in clinical development. Any probable conflicts of interest, which include funding from pharmaceutical providers or own inv